Treatment of acute exacerbation of asthma
78 results
1 - 78Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma: Cochrane systematic review
Ketamine for management of acute exacerbations of asthma in children
Anticholinergic therapy for acute asthma in children: Cochrane systematic review
Corticosteroids for preventing relapse following acute exacerbations of asthma: Cochrane systematic review
Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
Inhaled steroids for acute asthma following emergency department discharge
Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department: Cochrane systematic review
Combined inhaled anticholinergics and short-acting beta 2 -agonists for initial treatment of acute asthma in children: Cochrane systematic review
Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews
Inhaled anticholinergics and short-acting beta 2 -agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital: Cochrane systematic review
Caseworker‐assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness
Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma
Interventions for managing asthma in pregnancy: Cochrane systematic review
Different oral corticosteroid regimens for acute asthma
Exhaled nitric oxide levels to guide treatment for adults with asthma
Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children
Heliox for non‐intubated acute asthma patients
Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma
Antibiotics for exacerbations of asthma
Intravenous magnesium sulfate for treating children with acute asthma in the emergency department: Cochrane systematic review
Commercial versus home‐made spacers in delivering bronchodilator therapy for acute therapy in children
Exhaled nitric oxide levels to guide treatment for children with asthma
Breathing exercises for children with asthma
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
Inhaled magnesium sulfate in the treatment of acute asthma
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Education interventions for adults who attend the emergency room for acute asthma
Addition of intravenous aminophylline to inhaled beta2‐agonists in adults with acute asthma
Continuous versus intermittent beta‐agonists for acute asthma
Written action plans for asthma in children
Corticosteroids for hospitalised children with acute asthma
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma
Indigenous healthcare worker involvement for Indigenous adults and children with asthma
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Azoles for allergic bronchopulmonary aspergillosis associated with asthma
Combination inhaled corticosteroids and long‐acting beta2‐agonists for children and adults with bronchiectasis
Pneumococcal vaccine for asthma
Psychological interventions for children with asthma
Addition of long‐acting beta2‐agonists to inhaled corticosteroids for chronic asthma in children
Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
Vilanterol and fluticasone furoate for asthma
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
Cow's milk protein avoidance and development of childhood wheeze in children with a family history of atopy: Cochrane systematic review
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
Zinc for the common cold: Cochrane systematic review